Cholesterol differentially modulates the activity of opioid and muscarinic receptors via a common binding site
Preprint
Abstract
G protein-coupled receptors (GPCRs) are membrane proteins that represent the largest and most therapeutically targeted receptor class, accounting for 30% of currently marketed drugs. Two binding motifs for membrane cholesterol, the cholesterol recognition amino acid consensus (CRAC) domain and the cholesterol consensus motif (CCM), have been postulated. Using a simulation of the molecular dynamics of cholesterol association with the receptor, we predicted the binding of membrane cholesterol to non-canonical sites, distinct from CRAC and CCM, at muscarinic and opioid receptors. We identified a binding site common to muscarinic and opioid receptors at TM6, with arginine 6.35 as the major residue. Membrane cholesterol depletion mimics the effects of R 6.35 mutations, confirming its role in receptor modulation. Targeting cholesterol-binding sites offers novel pharmacotherapeutic strategies, including tissue-specific sterol-based modulation. One sentence summary: This study identifies a shared non-canonical cholesterol-binding site at TM6 in muscarinic and opioid receptors, with significant implications for drug development targeting tissue-specific GPCR modulation.Keywords
All Related Versions
- Published version: Biochemical Pharmacology, 242 (Pt 1), 117296.
Funding Information
- Ministry of Education Youth and Sports
- Czech Academy of Sciences (RVO:67985823)
- Ministry of Education, Sports and Youth (LM2015042)
This publication has 69 references indexed in Scilit:
- CHARMM-GUIMembrane Buildertoward realistic biological membrane simulationsJournal of Computational Chemistry, 2014
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJournal of Computer-Aided Molecular Design, 2013
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Membrane partitioning of various δ-opioid receptor forms before and after agonist activations: The effect of cholesterolBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- A fast, scalable method for the parallel evaluation of distance‐limited pairwise particle interactionsJournal of Computational Chemistry, 2005
- The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 2005
- Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force fieldProteins: Structure, Function, and Bioinformatics, 2002
- Steroids and opioid receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- cAMP accumulation in opioid-sensitive SH-SY5Y neuroblastoma cells is modified by estradiol and progesteroneMolecular and Cellular Endocrinology, 1991